Opportunities Preloader

Please Wait.....

Report

Global Clinical Trials Market Report and Forecast 2023-2031

Market Report I 2023-04-27 I 147 Pages I EMR Inc.

Global Clinical Trial Market Report and Forecast 2023-2031

Global Clinical Trial Market Outlook

The clinical trial market size attained a value of USD 46.7 Billion in 2022. The market is anticipated to grow at a CAGR of 5.40% during the forecast period of 2023-2031 to attain a value of nearly USD 75 billion by 2031.

Clinical Trial Market: Introduction
Clinical trials are research studies involving human participants, designed to evaluate the safety, efficacy, and optimal usage of medical interventions. These interventions can include drugs, medical devices, vaccines, diagnostic tools, surgical procedures, or behavioural therapies. Clinical trials play a crucial role in the development of new treatments and advancements in medical practice, as they provide evidence-based information on the safety and effectiveness of these interventions.
Clinical trials typically follow a structured process and are conducted in various phases, with each phase focusing on a specific aspect of the intervention. These phases range from Phase 0, which involves exploratory studies, to Phase 4, which includes post-marketing surveillance. The trials are conducted under strict ethical and regulatory guidelines to ensure the safety of participants and the validity of the results.
Applications of Clinical Trials:
- Drug development: Clinical trials are an essential part of the drug development process, as they help determine the safety, efficacy, dosage, and potential side effects of new medications. Data collected from these trials is critical for regulatory approval and the eventual introduction of new drugs into the market.
- Medical devices: Clinical trials are also used to evaluate the safety and effectiveness of medical devices, such as implants, diagnostic tools, and surgical instruments. These studies provide insights into the performance of the device, possible risks, and overall benefits for patients.
- Treatment protocols: Clinical trials can help establish the most effective treatment protocols and guidelines for various medical conditions. By comparing different approaches, researchers can determine the best course of action for specific patient populations.
- Disease prevention: Clinical trials play a significant role in the development of preventive measures, such as vaccines or lifestyle interventions, to reduce the incidence of diseases and improve overall public health.
- Quality of life improvement: In addition to evaluating the direct effects of medical interventions, clinical trials often examine their impact on patients' quality of life. This information can help healthcare providers make informed decisions about treatment options and patient care.
In summary, clinical trials are a fundamental aspect of medical research, providing valuable insights into the safety, efficacy, and optimal use of medical interventions. They play a crucial role in the development of new treatments, devices, and preventive measures, ultimately contributing to the advancement of medical practice and the improvement of patient outcomes.
Clinical Trial Market Segmentations
The market can be categorised into segments like design, phase, service type, therapy area, application, and region.
Market Breakup by Design
- Treatment Studies
o Randomised Control Trial
o Adaptive Clinical Trail
o Non- Randomised Control Trial

- Observational Studies
o Cohort Studies
o Case Control Studies
o Cross Section Study
o Ecological Study
o Others

Market Breakup by Phase
- Phase I
- Phase II
- Phase III
- Phase IV

Market Breakup by Service Type
- Site Identification
- Patient Recruitment
- Laboratory Services
- Analytical Testing Services
- Bio-Analytical Testing Services
o Cell Based Assay
o Virology Testing
o PK/PD Testing Services
o Method Development, Optimization, Validation
o Serology, Immunogenicity and Neutralizing Antibodies
o Bio Marker Testing Service
o Other Bioanalytical Testing Services
- Clinical Trial Data Management Services
- Clinical Trial Supply and Logistic Services
- Medical Device Testing Services
- Other Clinical Trial Services

Market Breakup by Therapy Area
- Oncology
- Infectious Disease
- Neurology
- Immunology
- Cardiology
- Genetic Disease
- Women's Health
- Other Therapy Areas

Market Breakup by Application
- Small Molecule
- Vaccine
- Cell and Gene Therapy
- Other Applications
Clinical Trial Market Breakup by Region
- North America
- United States of America
- Canada
- Europe
- United Kingdom
- Germany
- France
- Italy
- Others
- Asia Pacific
- China
- Japan
- India
- ASEAN
- Australia
- Others
- Latin America
- Brazil
- Argentina
- Mexico
- Others
- Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Nigeria
- South Africa
- Others


Clinical Trial Market Scenario

The clinical trial market has been experiencing consistent growth, fuelled by various factors that contribute to its expansion and evolution. These factors include an increase in the number of chronic diseases, advancements in technology, and a greater focus on personalized medicine.
The clinical trial market has experienced notable growth due to key drivers and developments, such as the rising prevalence of chronic diseases necessitating innovative treatments, technological advancements that streamline trial processes and enable decentralized trials, and the focus on personalized medicine for targeted therapies. Additionally, supportive regulatory policies expedite approval processes for ground-breaking treatments, particularly in areas with unmet medical needs or rare diseases. The expansion of clinical research into emerging markets, with their large patient populations and lower operational costs, has also significantly contributed to the growth and evolution of the clinical trial market.
In conclusion, the clinical trial market has been growing steadily due to a combination of factors, including the rising prevalence of chronic diseases, technological advancements, and the focus on personalized medicine. The future outlook for the market remains promising, with ongoing innovations and developments in medical research expected to drive further growth and expansion in the coming years.

Key Players in the Global Clinical Trial Market

The report gives an in-depth analysis of the key players involved in the clinical trial market, sponsors manufacturing the drugs, and putting them through trials to get FDA approvals. The companies included in the market are as follows:

- IQVIA
- PAREXEL International Corporation
- Charles River Laboratory
- ICON Plc
- Financial Analysis
- Syneos Health
- Labcorp Drug Development (COVANCE)
- Wuxi Apptec
- Charles River Laboratories
- PPD Inc
- ICON Plc
- Medpace Holdings Inc
- Acm Global Laboratories
- Advanced Clinical
- SGS
- PSI CRO AG
- Bio Agile Therapeutics

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Clinical Trial Market Overview
3.1 Global Clinical Trial Market Historical Value (2016-2022)
3.2 Global Clinical Trial Market Forecast Value (2023-2031)
4 Global Clinical Trial Market Landscape
4.1 Global Clinical Trial Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Clinical Trial Product Landscape
4.2.1 Analysis by Service Type
4.2.2 Analysis by Design
4.2.3 Analysis by Therapy Area
5 Global Clinical Trial Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter's Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Clinical Trial Market Segmentation
6.1 Global Clinical Trial Market by Design
6.1.1 Market Overview
6.1.2 Treatment Studies
6.1.2.1 Randomised Control Trial
6.1.2.2 Adaptive Clinical Trail
6.1.2.3 Non- Randomised Control Trial
6.1.3 Observational Studies
6.1.3.1 Cohort Studies
6.1.3.2 Case Control Studies
6.1.3.3 Cross Section Study
6.1.3.4 Ecological Study
6.1.3.5 Others
6.2 Global Clinical Trial Market by Phase
6.2.1 Market Overview
6.2.2 Phase I
6.2.3 Phase II
6.2.4 Phase III
6.2.5 Phase IV
6.3 Global Clinical Trial Market by Service Type
6.3.1 Market Overview
6.3.2 Site Identification
6.3.3 Patient Recruitment
6.3.4 Laboratory Services
6.3.5 Analytical Testing Services
6.3.6 Bio-Analytical Testing Services
6.3.6.1 Cell Based Assay
6.3.6.2 Virology Testing
6.3.6.3 PK/PD Testing Services
6.3.6.4 Method Development, Optimization, Validation
6.3.6.5 Serology, Immunogenicity & Neutralizing Antibodies
6.3.6.6 Bio Marker Testing Service
6.3.6.7 Other Bioanalytical Testing Services
6.3.7 Clinical Trial Data Management Services
6.3.8 Clinical Trial Supply and Logistic Services
6.3.9 Medical Device Testing Services
6.3.10 Other Clinical Trial Services
6.4 Global Clinical Trial Market by Therapy Area
6.4.1 Market Overview
6.4.2 Oncology
6.4.3 Infectious Disease
6.4.4 Neurology
6.4.5 Immunology
6.4.6 Cardiology
6.4.7 Genetic Disease
6.4.8 Women's Health
6.4.9 Other Therapy Areas
6.5 Global Clinical Trial Market by Application
6.5.1 Market Overview
6.5.2 Small Molecule
6.5.3 Vaccine
6.5.4 Cell & Gene Therapy
6.5.5 Other Applications
6.6 Global Clinical Trial Market by Region
6.6.1 Market Overview
6.6.2 North America
6.6.3 Europe
6.6.4 Asia Pacific
6.6.5 Latin America
6.6.6 Middle East and Africa
7 North America Clinical Trial Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Clinical Trial Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Clinical Trial Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Clinical Trial Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Clinical Trial Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 IQVIA
17.1.1 Financial Analysis
17.1.2 Service Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 PAREXEL International Corporation
17.2.1 Financial Analysis
17.2.2 Service Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Charles River Laboratory
17.3.1 Financial Analysis
17.3.2 Service Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 ICON Plc
17.4.1 Financial Analysis
17.4.2 Service Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Syneos Health
17.5.1 Financial Analysis
17.5.2 Service Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Labcorp Drug Development (COVANCE)
17.6.1 Financial Analysis
17.6.2 Service Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Wuxi Apptec
17.7.1 Financial Analysis
17.7.2 Service Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Charles River Laboratories
17.8.1 Financial Analysis
17.8.2 Service Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 PPD Inc
17.9.1 Financial Analysis
17.9.2 Service Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 ICON Plc
17.10.1 Financial Analysis
17.10.2 Service Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 Medpace Holdings Inc
17.11.1 Financial Analysis
17.11.2 Service Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 Acm Global Laboratories
17.12.1 Financial Analysis
17.12.2 Service Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
17.13 Advanced Clinical
17.13.1 Financial Analysis
17.13.2 Service Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.13.5 Certifications
17.14 SGS
17.14.1 Financial Analysis
17.14.2 Service Portfolio
17.14.3 Demographic Reach and Achievements
17.14.4 Mergers and Acquisitions
17.14.5 Certifications
17.15 PSI CRO AG
17.15.1 Financial Analysis
17.15.2 Service Portfolio
17.15.3 Demographic Reach and Achievements
17.15.4 Mergers and Acquisitions
17.15.5 Certifications
17.16 Bio Agile Therapeutics
17.16.1 Financial Analysis
17.16.2 Service Portfolio
17.16.3 Demographic Reach and Achievements
17.16.4 Mergers and Acquisitions
17.16.5 Certifications
18 Global Clinical Trial Market- Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket

  • Not Sure / Need Reassuring
    • Confirm Content
      • Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:

        Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.

        Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.

        Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.

    • Sample Pages
      • With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.

        It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.

        To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Check for Alternatives
      • Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.

        To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.

  • Prices / Formats / Delivery
    • Prices
      • All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.

        Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Discounts
      • As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.

        Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.

        To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Available Currencies
      • Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.

        Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.

        To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.

    • Licenses
      • License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.

        If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.

    • Global Site License
      • The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.

        It is important to note that this may exclude Parent Companies or Subsidiaries.

        If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.

    • Formats
      • The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.

        If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.

    • Delivery
      • Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.

        Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.

        If a delay in delivery is expected you will be informed about it immediately.

    • Shipping Charges
      • As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.

        If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.

  • Ordering
    • By Credit Card
      • We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.

        Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.

        For more information on PayU please visit: https://www.payu.pl/en/about-us

    • By Money Transfer
      • If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.

        With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.

  • Security
    • Website security
      • We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.

        Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.

    • Credit Card Security
      • We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.

        PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.

PLEASE SELECT LICENSE